IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 79 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $13,000 | -7.1% | 10,200 | +32.5% | 0.01% | 0.0% |
Q1 2018 | $14,000 | -6.7% | 7,700 | +6.9% | 0.01% | -14.3% |
Q4 2017 | $15,000 | +200.0% | 7,200 | +200.0% | 0.01% | +250.0% |
Q3 2017 | $5,000 | -28.6% | 2,400 | -41.5% | 0.00% | -50.0% |
Q2 2017 | $7,000 | -22.2% | 4,100 | +13.9% | 0.00% | -20.0% |
Q1 2017 | $9,000 | +80.0% | 3,600 | 0.0% | 0.01% | +66.7% |
Q4 2016 | $5,000 | -58.3% | 3,600 | -25.0% | 0.00% | -57.1% |
Q3 2016 | $12,000 | +71.4% | 4,800 | -2.0% | 0.01% | +75.0% |
Q2 2016 | $7,000 | -30.0% | 4,900 | 0.0% | 0.00% | -33.3% |
Q1 2016 | $10,000 | -33.3% | 4,900 | 0.0% | 0.01% | -25.0% |
Q4 2015 | $15,000 | -6.2% | 4,900 | 0.0% | 0.01% | -20.0% |
Q3 2015 | $16,000 | -5.9% | 4,900 | +6.5% | 0.01% | 0.0% |
Q2 2015 | $17,000 | +13.3% | 4,600 | +12.2% | 0.01% | +11.1% |
Q1 2015 | $15,000 | – | 4,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,200,700 | $13,059,000 | 1.26% |
Cormorant Asset Management, LP | 400,000 | $1,632,000 | 0.38% |
NATIXIS | 3,149,116 | $12,849,000 | 0.17% |
WALL STREET ASSOCIATES | 500,000 | $2,040,000 | 0.17% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $1,517,000 | 0.14% |
CARL DOMINO INC | 45,137 | $184,000 | 0.10% |
HOLLENCREST CAPITAL MANAGEMENT | 142,000 | $580,000 | 0.09% |
Baker Brothers Advisors | 1,613,076 | $6,581,000 | 0.08% |
LEAVELL INVESTMENT MANAGEMENT, INC. | 81,271 | $332,000 | 0.06% |
MARSHALL WACE, LLP | 572,305 | $2,335,000 | 0.04% |